ホーム › クローン病 › ジョージア州 › Atlanta
Atlanta、GAにおけるクローン病の臨床試験
Atlantaとその周辺地域（約30マイル以内）の拠点で、クローン病に関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
被験者募集中第3相
- Morehouse School Of Medicine ( Site 5071), Atlanta
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
被験者募集中第4相
- Digestive Healthcare of Georgia, Atlanta
- AGA GA Research LLC, Atlanta
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Emory University, Atlanta
- Children's Center for Digestive Health Care, Atlanta
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第2相
- Emory University Hospital, The Emory Clinic, Atlanta
- Atlanta Center For Gastroenterology, P.C., Decatur · 6マイル先
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Morehouse School of Medicine, Atlanta
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
被験者募集中第3相
- Emory University, Atlanta
- Children's Center for Digestive Healthcare, Atlanta
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第2/3相
- Emory University, Atlanta
- Children's Center for Digestive Health Care, Atlanta
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Atlanta Gastroenterology Associates-Site Number: 8400109, Atlanta
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
被験者募集中第3相
- Emory University School of Medicine, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
被験者募集中第2相
- Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
被験者募集中第2相
- Atlanta Gastroenterology Specialists, PC, Atlanta
- Atlanta Gastroenterology Associates (Part of United Digestive), Atlanta
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
被験者募集中第2相
- Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
被験者募集中第3相
- Emory University, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
被験者募集中第4相
- Emory University, Atlanta
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
被験者募集中第3相
- Childrens Center For Digestive Healthcare, Atlanta
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
被験者募集中第3相
- Childrens Center For Digestive Healthcare, Atlanta
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
被験者募集中第2相
- Mirador Therapeutics Selected Site, Atlanta
他の都市におけるクローン病の試験
- New York City, NY35件の研究
- Boston, MA19件の研究
- Miami, FL19件の研究
- Cleveland, OH19件の研究
- St. Louis, MO19件の研究
- Tyler, TX17件の研究
- Houston, TX17件の研究
- Orlando, FL17件の研究
- San Antonio, TX15件の研究
- San Diego, CA15件の研究
- Los Angeles, CA15件の研究
- Colorado Springs, CO13件の研究
Atlantaにおける他の研究
- がん（全種類）49件の研究
- 非小細胞肺癌47件の研究
- 多発性骨髄腫42件の研究
- 乳がん41件の研究
- 前立腺がん33件の研究
- 急性骨髄性白血病31件の研究
- 卵巣がん29件の研究
- 大腸癌29件の研究
- 肺がん29件の研究
- 転移性癌28件の研究
- 大うつ病性障害25件の研究
- 心不全25件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。